NOVAREX Co.Ltd (194700) - Total Liabilities

Latest as of March 2026: ₩112.55 Billion KRW ≈ $76.27 Million USD

Based on the latest financial reports, NOVAREX Co.Ltd (194700) has total liabilities worth ₩112.55 Billion KRW (≈ $76.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NOVAREX Co.Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

NOVAREX Co.Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how NOVAREX Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 194700 total assets.

NOVAREX Co.Ltd Competitors by Total Liabilities

The table below lists competitors of NOVAREX Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Neumora Therapeutics, Inc.
NASDAQ:NMRA
USA $45.67 Million
Monte Carlo Fashions Limited
NSE:MONTECARLO
India Rs11.19 Billion
enGene Holdings Inc. Common Stock
NASDAQ:ENGN
USA $58.03 Million
Lalin Property Public Company Limited
BK:LALIN
Thailand ฿8.19 Billion
Zapata Computing Holdings Inc. Common Stock
NASDAQ:ZPTA
USA $19.36 Million
vTv Therapeutics Inc
NASDAQ:VTVT
USA $8.96 Million
Bank Negara Indonesia Tbk
JK:BBNI
Indonesia Rp1036.47 Trillion
Global Lithium Resources Ltd
AU:GL1
Australia AU$3.47 Million

Liability Composition Analysis (2015–2025)

This chart breaks down NOVAREX Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 194700 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.19 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NOVAREX Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NOVAREX Co.Ltd (2015–2025)

The table below shows the annual total liabilities of NOVAREX Co.Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 ₩104.91 Billion
≈ $71.10 Million
+51.29%
2024-12-31 ₩69.35 Billion
≈ $47.00 Million
+7.82%
2023-12-31 ₩64.32 Billion
≈ $43.59 Million
-27.91%
2022-12-31 ₩89.21 Billion
≈ $60.46 Million
-22.40%
2021-12-31 ₩114.96 Billion
≈ $77.91 Million
+15.09%
2020-12-31 ₩99.89 Billion
≈ $67.70 Million
+59.62%
2019-12-31 ₩62.58 Billion
≈ $42.41 Million
+128.43%
2018-12-31 ₩27.40 Billion
≈ $18.57 Million
+37.52%
2017-12-31 ₩19.92 Billion
≈ $13.50 Million
+27.79%
2016-12-31 ₩15.59 Billion
≈ $10.56 Million
-21.77%
2015-12-31 ₩19.93 Billion
≈ $13.51 Million
--

About NOVAREX Co.Ltd

KQ:194700 Korea Packaged Foods
Market Cap
$123.93 Million
₩182.87 Billion KRW
Market Cap Rank
#18476 Global
#835 in Korea
Share Price
₩10300.00
Change (1 day)
+1.28%
52-Week Range
₩10030.00 - ₩21050.00
All Time High
₩23604.80
About

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more